CVE-2024-1275Vulnerability in Baxter Welch Allyn Connex Spot Monitor
Updated under an hour ago ()
Does this affect you?
It affects Baxter Welch Allyn Connex Spot Monitor. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.39%, higher than 32% of scored CVEs.
Do this next
Free account, 1 product
Use of Default Cryptographic Key vulnerability in Baxter Welch Allyn Connex Spot Monitor may allow Configuration/Environment Manipulation.This issue affects Welch Allyn Connex Spot Monitor in all versions prior to 1.52.
- CVSS
- 9.1 CRITICAL (v4.0, CNA)CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N
- Weakness (CWE)
- CWE-1394
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.39% (percentile 32)
- Assigned by
- Baxter
- NVD analysis
- Deferred
- Record last updated
- Aug 1, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
Baxter Welch Allyn Connex Spot Monitor baxter:welch_allyn_connex_spot_monitor (from the name) | through 1.52 | CNA record |
baxter welch_allyn_connex_spot_monitor baxter:welch_allyn_connex_spot_monitor | through 1.52 | CISA ADP |
References
- https://www.cisa.gov/news-events/ics-medical-advisories/icsma-24-151-02
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.